AN ACT REQUIRING MEDICAID COVERAGE FOR FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE.
To require Medicaid coverage for gene therapies approved by the federal Food and Drug Administration to treat sickle cell disease.
Introduced by:
Human Services CommitteeNew today | 2-4 days old | 5 days & older |
Text of Bill | |
Public Act No. 25-63 [doc] | |
File No. 384 | |
HS Joint Favorable [doc] | |
Raised Bill [doc] |
Votes | |
House Roll Call Vote 265 | |
Senate Roll Call Vote 105 |
Committee Actions | |
HS Joint Fav. Rpt | |
HS Vote Tally Sheet (Joint Favorable) |
Fiscal Notes | |
Fiscal Note For File Copy 384 |
Bill Analyses | |
Bill Analysis For File Copy 384 | |
Summary for Public Act No. 25-63 |
Add Notes to SB-1473
Go To My Bills
This bill is in My Bills.
Do you wish to go to My Bills?
Co-sponsors for Amendment LCO:
Bill History
Date | Action Taken | ||
---|---|---|---|
6/23/2025 | Signed by the Governor | ||
6/9/2025 | Transmitted by Secretary of the State to Governor | ||
6/9/2025 | Transmitted to the Secretary of State | ||
6/3/2025 | (LCO) | Public Act 25-63 | |
5/31/2025 | In Concurrence | ||
5/31/2025 | House Passed | ||
5/2/2025 | House Calendar Number 526 | ||
5/2/2025 | Favorable Report, Tabled for the Calendar, House | ||
5/1/2025 | Senate Passed | ||
4/1/2025 | (LCO) | File Number 384 | |
4/1/2025 | Senate Calendar Number 235 | ||
4/1/2025 | Favorable Report, Tabled for the Calendar, Senate | ||
4/1/2025 | (LCO) | Reported Out of Legislative Commissioners' Office | |
3/25/2025 | (LCO) | Referred to Office of Legislative Research and Office of Fiscal Analysis 03/31/25 5:00 PM | |
3/17/2025 | (LCO) | Filed with Legislative Commissioners' Office | |
3/14/2025 | (HS) | Joint Favorable | |
3/7/2025 | Public Hearing 03/11 | ||
3/6/2025 | Referred to Joint Committee on Human Services |
Co-sponsors of SB-1473
NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.